eClinical Tech News

60 Degrees Pharmaceuticals Bolsters Cash Runway with $5 Million Public Offering 60 Degrees Pharmaceuticals has closed a public offering,...

Tevogen Secures Key AI Patent, Signaling Broader Shift in Biopharma R&D Tevogen has secured a patent for its AI-driven...

Iovance Biotherapeutics, a prominent player in the burgeoning field of tumor-infiltrating lymphocyte (TIL) therapies, recently granted stock options to...

Tevogen Bio Holdings (Nasdaq: TVGN) has secured a patent for its machine learning-driven system designed to predict immunologically active...

ARS Pharmaceuticals has secured UK approval for Eurneffy, its needle-free adrenaline nasal spray for anaphylaxis in adults and children...

ImCheck Therapeutics’ lead candidate, ict01, has received FDA orphan drug designation for acute myeloid leukemia (AML). This regulatory win...

Sanofi Bolsters Rare Disease Portfolio and Immunology Presence with Blueprint Medicines Acquisition Sanofi has finalized its acquisition of Blueprint...

Hookipa Pharma’s planned delisting from Nasdaq and subsequent dissolution signal the final chapter in the company’s independent journey. Following...

Merck’s Springworks Therapeutics secures landmark approval from the European Commission for Ezmekly (mirdametinib) for treating symptomatic, inoperable plexiform neurofibromas...

The European Commission has granted conditional marketing authorization to Springworks Therapeutics’ Ezmekly (mirdametinib) for treating symptomatic, inoperable plexiform neurofibromas...